Literature DB >> 20042648

Scotopic electrophysiology of the retina during transient hyperglycemia in type 2 diabetes.

Stig Kraglund Holfort1, Kristian Klemp, Peter Kristian Kofoed, Birgit Sander, Michael Larsen.   

Abstract

PURPOSE: To examine dark-adapted retinal function in subjects with type 2 diabetes during transient hyperglycemia.
METHODS: Twenty-four subjects with type 2 diabetes and minimal diabetic retinopathy were randomized to an oral glucose tolerance test (OGTT) or a fasting regimen. One study eye was kept in the dark-adapted state at all times. Full-field electroretinography (ffERG) and blood glucose measurements were performed at baseline and after 20, 80, 140, and 200 minutes.
RESULTS: Mean capillary glucose had increased 162% from the fasting baseline value when the concentration peaked in the OGTT group after 80 minutes (P < 0.0001). Concomitantly, rod b-wave amplitude had increased by 34% (P = 0.0007), whereas the a- and b-wave amplitudes of the standard combined rod-cone response had increased by 17% (P = 0.0013 and P = 0.0064). The dark-adapted 30-Hz flicker response was unaffected by hyperglycemia. The scotopic ffERG amplitudes rose and fell in phase with the glycemia. Implicit times did not change with the rise and fall in glycemia.
CONCLUSIONS: The change in scotopic signaling amplitude in the outer and middle layers of retina in subjects with diabetes was proportional to the change in capillary glucose. Cone amplitude was not influenced by hyperglycemia in this study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042648     DOI: 10.1167/iovs.09-4891

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Retinal function in relation to improved glycaemic control in type 1 diabetes.

Authors:  S K Holfort; K Nørgaard; G R Jackson; E Hommel; S Madsbad; I C Munch; K Klemp; B Sander; M Larsen
Journal:  Diabetologia       Date:  2011-04-26       Impact factor: 10.122

2.  Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy.

Authors:  M Tyrberg; U Lindblad; A Melander; M Lövestam-Adrian; V Ponjavic; S Andréasson
Journal:  Doc Ophthalmol       Date:  2011-11-06       Impact factor: 2.379

3.  Supplemental light exposure improves sleep architecture in people with type 2 diabetes.

Authors:  Prakash Adhikari; Asik Pradhan; Andrew J Zele; Beatrix Feigl
Journal:  Acta Diabetol       Date:  2021-04-14       Impact factor: 4.280

4.  Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy.

Authors:  Oliver N Klefter; Stig K Holfort; Michael Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-25       Impact factor: 3.117

5.  Electroretinography in healthy subjects in relation to systemic glucocorticoid intake.

Authors:  Per Kappelgaard; Katrine B Hansen; Tina Vilsbøll; Filip K Knop; Michael Larsen
Journal:  Doc Ophthalmol       Date:  2011-12-24       Impact factor: 2.379

Review 6.  Visual dysfunction associated with diabetic retinopathy.

Authors:  Gregory R Jackson; Alistair J Barber
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

7.  Macular thickness measurement in clinically significant macular edema before and after meal.

Authors:  Khalil Ghasemi Falavarjani; Joobin Khadamy; Foad Amirkourjani; Hamid Safi; Mehdi Modarres
Journal:  J Curr Ophthalmol       Date:  2016-02-01

8.  Deficient glucose and glutamine metabolism in Aralar/AGC1/Slc25a12 knockout mice contributes to altered visual function.

Authors:  Laura Contreras; Laura Ramirez; Jianhai Du; James B Hurley; Jorgina Satrústegui; Pedro de la Villa
Journal:  Mol Vis       Date:  2016-10-12       Impact factor: 2.367

9.  Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes.

Authors:  Leif E Johnson; Michael Larsen; Maria-Thereza Perez
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

Review 10.  Diabetic photoreceptors: Mechanisms underlying changes in structure and function.

Authors:  Silke Becker; Lara S Carroll; Frans Vinberg
Journal:  Vis Neurosci       Date:  2020-10-06       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.